Los Angeles Capital Management LLC Has $13.93 Million Stock Holdings in Bath & Body Works, Inc. (NYSE:BBWI)

Los Angeles Capital Management LLC lessened its holdings in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 63.2% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 322,765 shares of the company's stock after selling 554,802 shares during the quarter. Los Angeles Capital Management LLC owned about 0.14% of Bath & Body Works worth $13,931,000 as of its most recent filing with the SEC.

A number of other hedge funds also recently added to or reduced their stakes in BBWI. Federated Hermes Inc. raised its stake in shares of Bath & Body Works by 17.1% in the fourth quarter. Federated Hermes Inc. now owns 1,612 shares of the company's stock valued at $70,000 after acquiring an additional 235 shares in the last quarter. Commonwealth Equity Services LLC boosted its stake in shares of Bath & Body Works by 3.3% in the 3rd quarter. Commonwealth Equity Services LLC now owns 11,044 shares of the company's stock valued at $373,000 after buying an additional 348 shares during the period. CWM LLC grew its position in shares of Bath & Body Works by 7.3% during the fourth quarter. CWM LLC now owns 5,167 shares of the company's stock worth $223,000 after buying an additional 353 shares in the last quarter. DekaBank Deutsche Girozentrale grew its position in shares of Bath & Body Works by 1.3% during the fourth quarter. DekaBank Deutsche Girozentrale now owns 31,475 shares of the company's stock worth $1,349,000 after buying an additional 414 shares in the last quarter. Finally, Diversified Trust Co increased its stake in shares of Bath & Body Works by 1.9% during the fourth quarter. Diversified Trust Co now owns 23,663 shares of the company's stock worth $1,021,000 after buying an additional 435 shares during the period. 95.14% of the stock is currently owned by institutional investors and hedge funds.

Bath & Body Works Trading Up 4.9 %

Shares of NYSE BBWI traded up $2.14 during midday trading on Friday, reaching $45.97. 2,585,013 shares of the company were exchanged, compared to its average volume of 2,601,801. The stock has a fifty day simple moving average of $46.07 and a 200 day simple moving average of $41.03. The stock has a market cap of $10.34 billion, a P/E ratio of 11.94, a PEG ratio of 1.42 and a beta of 1.89. Bath & Body Works, Inc. has a 1 year low of $27.30 and a 1 year high of $50.34.

Bath & Body Works (NYSE:BBWI - Get Free Report) last released its earnings results on Thursday, February 29th. The company reported $2.06 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.85 by $0.21. Bath & Body Works had a negative return on equity of 37.01% and a net margin of 11.82%. The business had revenue of $2.91 billion for the quarter, compared to analyst estimates of $2.84 billion. During the same quarter in the previous year, the company posted $1.86 earnings per share. The company's revenue for the quarter was up .8% compared to the same quarter last year. As a group, analysts forecast that Bath & Body Works, Inc. will post 3.3 earnings per share for the current year.

Bath & Body Works Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, March 8th. Stockholders of record on Friday, February 23rd were paid a dividend of $0.20 per share. The ex-dividend date was Thursday, February 22nd. This represents a $0.80 dividend on an annualized basis and a dividend yield of 1.74%. Bath & Body Works's dividend payout ratio (DPR) is 20.78%.

Insider Buying and Selling

In other Bath & Body Works news, insider Thomas E. Mazurek sold 4,285 shares of Bath & Body Works stock in a transaction that occurred on Wednesday, March 27th. The stock was sold at an average price of $48.89, for a total value of $209,493.65. Following the sale, the insider now owns 45,992 shares of the company's stock, valued at approximately $2,248,548.88. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 0.19% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

BBWI has been the topic of a number of recent analyst reports. The Goldman Sachs Group increased their price objective on shares of Bath & Body Works from $49.00 to $56.00 and gave the company a "buy" rating in a research report on Monday, March 4th. Evercore ISI increased their price objective on Bath & Body Works from $30.00 to $45.00 and gave the company an "in-line" rating in a report on Friday, March 1st. BMO Capital Markets raised their target price on Bath & Body Works from $48.00 to $50.00 and gave the stock an "outperform" rating in a research report on Friday, March 1st. Wells Fargo & Company upped their price target on Bath & Body Works from $42.00 to $48.00 and gave the company an "equal weight" rating in a report on Wednesday, April 24th. Finally, Robert W. Baird boosted their price objective on shares of Bath & Body Works from $50.00 to $54.00 and gave the stock an "outperform" rating in a research report on Friday, March 1st. One research analyst has rated the stock with a sell rating, seven have issued a hold rating and six have given a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus price target of $46.73.

About Bath & Body Works

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.